Modulation of innate and acquired immune responses by Escherichia coli heat-labile toxin: Distinct pro- and anti-inflammatory effects of the nontoxic AB complex and the enzyme activity

Journal of Immunology

Volumn 165, Issue 10, 2000, Pages 5750-5759

  Ryan, E J ^a   McNeela, E ^a   Pizza, M ^a   Rappuoli, R ^a   O'Neill, L ^a   Mills, K H G ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; BACTERIAL TOXIN; BACTERIUM LIPOPOLYSACCHARIDE; CD86 ANTIGEN; CYCLIC AMP; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 5; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BORDETELLA PERTUSSIS; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; ESCHERICHIA COLI; FEMALE; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR TRANSPORT; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; TH1 CELL; TH2 CELL;

EID: 0034670024     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.10.5750     Document Type: Article

References (47)

1. A relationship between the structure and function of cholera and Escherichia coli heat labile enterotoxins and their immunological activity at mucosal surfaces
2. Immune modulation by cholera-like enterotoxins: From adjuvant to therapeutic
3. Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli heat labile enterotoxin
4. Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants
5. Genetically detoxified mutants of heat-labile toxin from Escherichia coli are able to act as oral adjuvants
6. Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity
7. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity
8. Mutational analysis of the role of ADP-ribosylation activity and GM1-binding activity in the adjuvant properties of the Escherichia coli heat-labile enterotoxin towards intranasally administered keyhole limpet hemocyanin
9. Mutants of Escherichia coli heat labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: Differential effects of the non-toxic AB complex and enzyme activity on Th1 and Th2 cells
10. + T lymphocytes
11. Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor β1 and β2 chain expression
12. Regulation of interferon-γ production by IL-12 and IL-18
13. The tarning of IL-12: Suppressing the production of proinflammatory cytokines
14. Regulation of macrophage IL-12 synthesis by Leishmania phosphoglycans
15. + T cells and dysregulated IL-12 production during HIV infection
16. Direct anti-inflammatory effect of a bacterial virulence factor: IL-10 dependent suppression of IL-12 production by filamentous hemagglutinin from Bordetella pertussis
17. The mucosal adjuvant effects of cholera toxin and immune-stimulating complexes differ in their requirement for IL-12, indicating different pathways of action
18. Prevention of autoimmune disease due to lymphocyte modulation by the B-subunit of Escherichia coli heat labile enterotoxin
19. The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile toxin is linked to their ADP-ribosyltransferase activity
20. Cell-mediated immunity to Bordetella pertussis: Role of Th1 cells in bacterial clearance in a murine respiratory infection model
21. Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells
22. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis
23. Murine T cell culture
24. Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: Adjuvant action is associated with enhanced regulatory cytokine production and expression of the costimulatory molecules B7-1, B7-2 and CD28
25. Interlukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice
26. Activation of NF-κB and induction of vascular cell adhesion molecule-1 and intracellular adhesion molecule-1 expression in human glial cells by IL-1: Modulation by antioxidants
27. Intestinal electrolyte transport and diarrheal diseases
28. + regulatory T-cells
29. Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 Th cells
30. Inhibition of class II major histocompatibility complex antigen processing by heat-labile enterotoxin requires an enzymatically active A subunit
31. Cholera toxin increases intracellular pH in B lymphoma cells and decreases their antigen-presenting ability
32. Cholera toxin B subunit binding to an antigen-presenting cell directly co-stimulates cytokine production from a T cell clone
33. IL-6 acts on endothelial cells to preferentially increase their adherence for lymphocytes
34. The mucosal adjuvanticity of cholera toxin involves enhancement of costimulatory activity by selective up-regulation of B7-2 expression
35. Genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit
36. Direct effects on antigen-presenting cells and T lymphocytes explain the adjuvanticity of a nontoxic cholera toxin mutant
37. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4
38. Measles: Immunosuppression, interleukin-12, and complement receptors
39. Glycosphingolipids as novel targets for T-cell suppression by the B subunit of recombinant heat-labile enterotoxin
40. Ceramide signalling and the immune response
41. Apoptosis by death factor
42. Cholera toxin discriminates between T helper 1 and 2 cells in a T cell receptor-mediated activation: Role of cAMP in T cell proliferation
43. 2-agonists prevent Th1 development by selective inhibition of interleukin-12
44. Cyclic AMP inhibits expression of the IL-2 gene through the nuclear factor of activated T cells (NF-AT) site, and transfection of NF-AT cDNAs abrogates the sensitivity of EL-4 cells to cyclic AMP
45. Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene
46. Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NFκB-mediated transcription